← Leaderboards
Teruna J. Siahaan
University Of Kansas Lawrence
$8,220,545
Attributed
$11,046,720
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,046,720 · 9
By mechanism
R01$7,426,311 · 7
T32$3,262,485 · 1
R56$357,924 · 1
Top collaborators
- Liqin Zhao9 shared
- David Volkin5 shared
- Krzysztof Kuczera2 shared
Most similar at University Of Kansas Lawrence
Same institution · by research overlap
- Liqin Zhao$4,859,507
- Krzysztof Kuczera$310,394
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseProteinsMediatingMouse ModelCadherinsPeptidesPreventBrainBlood - Brain Barrier AnatomyDesignSignal TransductionProductionFamilial Alzheimer DiseaseMutantDrug TargetingSynapsesE-CadherinKnock-In MouseApolipoprotein E-4Pharmacologic SubstanceDrug Delivery SystemsBiologicalIn Vitro
Grant awards (34)
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$578,222
R01 · FY2025 · AG
A Novel Method to Enhance Drug Delivery to the Brain$443,442
R01 · FY2025 · AG · contact PI
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$71,016
R01 · FY2025 · AG
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$764,401
R01 · FY2024 · AG
A Novel Method to Enhance Drug Delivery to the Brain$487,741
R01 · FY2024 · AG · contact PI
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$17,755
R01 · FY2024 · AG
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$585,478
R01 · FY2023 · AG
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$168,213
R01 · FY2023 · AG
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$580,933
R01 · FY2022 · AG
Pharmaceutical Aspects of Biotechnology$267,906
T32 · FY2018 · GM · contact PI
Pharmaceutical Aspects of Biotechnology$350,172
T32 · FY2017 · GM · contact PI
Pharmaceutical Aspects of Biotechnology$346,129
T32 · FY2016 · GM · contact PI
Pharmaceutical Aspects of Biotechnology$342,192
T32 · FY2015 · GM · contact PI
Modulating the BBB to Improve Drug Delivery to the Brain$304,650
R01 · FY2015 · NS · contact PI
Pharmaceutical Aspects of Biotechnology$338,356
T32 · FY2014 · GM · contact PI
Modulating the BBB to Improve Drug Delivery to the Brain$301,645
R01 · FY2014 · NS · contact PI
Pharmaceutical Aspects of Biotechnology Training$306,632
T32 · FY2013 · GM · contact PI
Modulating the BBB to Improve Drug Delivery to the Brain$277,995
R01 · FY2013 · NS · contact PI
Pharmaceutical Aspects of Biotechnology Training$332,828
T32 · FY2012 · GM · contact PI
Modulating the BBB to Improve Drug Delivery to the Brain$305,551
R01 · FY2012 · NS · contact PI
Pharmaceutical Aspects of Biotechnology Training$329,096
T32 · FY2011 · GM · contact PI
Modulating the BBB to Improve Drug Delivery to the Brain$326,568
R01 · FY2011 · NS · contact PI
Tergeting LFA-1 for Delivering Antigenic Peptides$357,924
R56 · FY2010 · AI · contact PI
Pharmaceutical Aspects of Biotechnology Training$325,467
T32 · FY2010 · GM · contact PI
Pharmaceutical Aspects of Biotechnology Training$323,707
T32 · FY2009 · GM · contact PI
Targeting and Internalization Mechanism of LFA-1$264,626
R01 · FY2008 · AI · contact PI
Targeting and Internalization Mechanism of LFA-1$269,836
R01 · FY2007 · AI · contact PI
Targeting and Internalization Mechanism of LFA-1$277,978
R01 · FY2006 · AI · contact PI
Targeting and Internalization Mechanism of LFA-1$238,369
R01 · FY2005 · AI
Modulation of the Intercellular Junction Cadherins$229,163
R01 · FY2004 · EB
Modulation of the Intercellular Junction Cadherins$229,163
R01 · FY2003 · EB
Modulation of the Intercellular Junction Cadherins$222,611
R01 · FY2002 · EB
Modulation of the Intercellular Junction Cadherins$224,658
R01 · FY2001 · CA
IMPROVING BIOAVAILABILITY OF RGD PEPTIDOMIMETICS$256,297
R01 · FY2000 · HL